Continuing Medical Education: November 2016 Instructions

摘要

Current treatment options for inflammatory bowel disease (IBD) include 5-aminosaDSEEElicates, corticosteroids, immunomodulatory therapy, biologic therapy and surgery. Treatment is traditionally a step wise progression, however to-date the main clinical consideration has been when to 'step up'. Newer therapies available for IBD offer 'choices' at several steps of the treatment algorithm. In addition, clinical and biochemical markers of prognosis and response to therapy are becoming increasingly relevant to better characterize prognosis and assess response. This supplement reviews the emerging opportunities for a more patient-centered individualized approach to management and makes some expert opinion recommendations on the choices now available to physicians.